| Authors: |
Moll K; IBM Consulting, Bethesda, MD, USA., Lufkin B; Acumen LLC, Burlingame, CA, USA., Fingar KR; IBM Consulting, Bethesda, MD, USA., Ke Zhou C; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Tworkoski E; Acumen LLC, Burlingame, CA, USA., Shi C; Acumen LLC, Burlingame, CA, USA., Hobbi S; IBM Consulting, Bethesda, MD, USA., Hu M; Acumen LLC, Burlingame, CA, USA., Sheng M; IBM Consulting, Bethesda, MD, USA., McCarty J; IBM Consulting, Bethesda, MD, USA., Shangguan S; Acumen LLC, Burlingame, CA, USA., Burrell T; IBM Consulting, Bethesda, MD, USA., Chillarige Y; Acumen LLC, Burlingame, CA, USA., Beers J; IBM Consulting, Bethesda, MD, USA., Saunders-Hastings P; Gevity Inc, an Accenture Company, Ottawa, Canada., Muthuri S; IBM Consulting, Bethesda, MD, USA., Edwards K; IBM Consulting, Bethesda, MD, USA., Black S; IBM Consulting, Bethesda, MD, USA., Kelman J; Centers for Medicare & Medicaid Services, Baltimore, MD, USA., Reich C; IQVIA, Falls Church, VA, USA., Amend KL; Optum Epidemiology, Boston, MA, USA., Djibo DA; Aetna, Blue Bell, PA, USA., Beachler D; HealthCore, Inc, Wilmington, DE, USA., Ogilvie RP; Optum Epidemiology, Boston, MA, USA., Secora A; IQVIA, Falls Church, VA, USA., McMahill-Walraven CN; Aetna, Blue Bell, PA, USA., Seeger JD; Optum Epidemiology, Boston, MA, USA., Lloyd P; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Thompson D; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Dimova R; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., MaCurdy T; Acumen LLC, Burlingame, CA, USA; Department of Economics, Stanford University, Stanford, CA, USA., Obidi J; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Anderson S; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Forshee R; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Wong HL; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Shoaibi A; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA. Electronic address: Azadeh.Shoaibi@fda.hhs.gov. |
